Post-IPO Equity - Sequenom
Investment Firm
Overview
Sequenom provides genetic analysis products and diagnostic tests for non-invasive prenatal genetic disorders.
Announced Date
Dec 29, 2009
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
1
No investment info available on this profile
Round Details and Background
Sequenom raised $1512015 on 2009-12-29 in Post-IPO Equity
Sequenom provides genetic analysis products and diagnostic tests for non-invasive prenatal genetic disorders.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Nov 08, 2001 |  Grant - Sequenom | 1 | - | 2.2M |
| Dec 29, 2009 | Post-IPO Equity - Sequenom | - | 1.5M | |
| May 21, 2010 | Post-IPO Equity - Sequenom | - | 51.6M | |
| Sep 24, 2012 | Post-IPO Debt - Sequenom | - | 130.0M |
Recent Activity
There is no recent news or activity for this profile.